Mito in the News


Alexion Pharmaceuticals and Stealth Announce Agreement for Option to Co-Develop and Commercialize Late-Stage Therapy for Mitochondrial Diseases

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Stealth BioTherapeutics Corp(NASDAQ:MITO) today announced an agreement for an option to co-develop and commercialize elamipretide for mitochondrial diseases. Currently being evaluated in a Phase...


Stealth BioTherapeutics Presents Data for Elamipretide on Cardiac Function in Barth Syndrome

BOSTON, Oct. 17, 2019 /PRNewswire/ — Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction,...


Parents Decide to Withdraw Treatment Request for Little Charlie Gard

The thoughts and prayers of the entire mitochondrial disease community are with Charlie Gard and his mother and father, Chris Gard and Connie Yates. They have decided to withdraw...


Courtagen Life Sciences Shifts Focus to its Medicinal Cannabis Genetics and Testing Business

Woburn, Mass.–(BUSINESS WIRE)—Courtagen Life Sciences Inc. announced today that the company will be shifting the core focus of its business to medicinal cannabis genetics and testing. As the company...


Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study of Omaveloxolone in Patients with Mitochondrial Myopathies

IRVING, Texas, March 01, 2018 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced top-line data from the dose-escalation cohorts of the...


How Calderdale will be showing its support and lighting up green for Mito Awareness Week

Emma Beal, left, and Kerry Ellis (actress and singer best known for her work in musical theatre and subsequent crossover into music) showing her support for #KissGoodbyeToMito The historic...


Stealth BioTherapeutics Presents Data on SBT-272 in Neurodegeneration

BOSTON, Oct. 7, 2019 /PRNewswire/ — Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction,...


Video: Free Derry tribute to Beibhínn to raise awareness of ‘Mito’ disease

The family and friends of Beibhnns Hegarty-Devine at Free Derry corner including parents Carla & Kevin, on right. The family of beautiful baby girl, Beibhínn Hegarty-Devine, who sadly passed...


Little Lola’s parents walk to save future ‘mito’ sufferers

The parents of five-year-old Lola Lloyd will be walking more than seven hours this Sunday (October 13) to raise awareness and funds for mitochondrial, or mito, a debilitating and...